RELX PLC provides analytics and decision tools for professional customers globally. The company operates four segments: Risk, Scientific, Technical & Medical, Legal, and Exhibitions. The Risk segment offers risk evaluation and prediction tools combining public content with technology. The Scientific, Technical & Medical segment provides information and data sets for researchers and healthcare professionals. The Legal segment offers legal, regulatory, and business information and analytics for decision-making. The Exhibitions segment combines face-to-face events with digital tools for market learning and transactions. The company was previously known as Reed Elsevier PLC before changing its name to RELX PLC in 2015.
Indicator | Value |
---|---|
PER | 33.4 |
EV/EBITDA | 19.8 |
Price/Free Cash Flow' | 30.4 |
ROIC | 26.3% |
Net Debt/EBITDA | 1.8 |